Oxagen is a biopharmaceutical company that provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases.
Oxagen total Funding
Oxagen latest funding size
Time since last funding
|11 years ago|
|Bessemer Venture Partners, 3i Group, MPM Capital, Novartis Venture Fund, Abingworth, SV Health Investors|
Revenue (FY, 2015)
Net income (FY, 2015)
EBIT (FY, 2015)
|GBP||FY, 2014||FY, 2015|
Depreciation and amortization
EBIT margin, %
|GBP||FY, 2014||FY, 2015||FY, 2016||FY, 2017||FY, 2018|
When was Oxagen founded?
Oxagen was founded in 1997.
Who are Oxagen key executives?
Oxagen's key executives are Timothy Edwards and Regina Hodits.
How many employees does Oxagen have?
Oxagen has 9 employees.
What is Oxagen revenue?
Latest Oxagen annual revenue is £24.2 k.
What is Oxagen revenue per employee?
Latest Oxagen revenue per employee is £2.7 k.
Who are Oxagen competitors?
Competitors of Oxagen include Innovus Pharmaceuticals, Aimmune Therapeutics and GT Biopharma.
Where is Oxagen headquarters?
Oxagen headquarters is located at 99 Park Dr, Abingdon.
Where are Oxagen offices?
Oxagen has an office in Abingdon.
How many offices does Oxagen have?
Oxagen has 1 office.
Receive alerts for 300+ data fields across thousands of companies